Clinical Trial Update: 68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction [EARLY_Phase 1]

View source ↗

Summary

This early-phase study reports on the evaluation of the PET tracer 68Ga-BNOTA-PRGD2 for imaging myocardial infarction in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• 68Ga-BNOTA-PRGD2

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Coronary Artery Disease | EARLY_Phase 1 | Status: UNKNOWN